Tekla Healthcare Investors (HQH) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.008x

Based on the latest financial reports, Tekla Healthcare Investors (HQH) has a cash flow conversion efficiency ratio of 0.008x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($8.72 Million) by net assets ($1.06 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tekla Healthcare Investors (HQH) market capitalisation for the company's overall valuation and market capitalisation.

Tekla Healthcare Investors - Cash Flow Conversion Efficiency Trend (1996–2014)

This chart illustrates how Tekla Healthcare Investors's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tekla Healthcare Investors Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tekla Healthcare Investors ranked by their cash flow conversion efficiency. Explore HQH cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Eerly Govt Ppty Inc
NYSE:DEA
0.020x
Margun Enerji Uretim Sanayi ve Ticaret AS
IS:MAGEN
-0.037x
Winmark Corporation
NASDAQ:WINA
-0.285x
Enovis Corp
NYSE:ENOV
0.051x
Leshan Giantstar Farming & Husbandry Corp Ltd
SHG:603477
0.132x
Metsa Board Oyj B
HE:METSB
-0.005x
CSG Holding Co Ltd
SHE:000012
0.034x
Wuhan Fingu Electronic Technology Co Ltd
SHE:002194
0.036x

Annual Cash Flow Conversion Efficiency for Tekla Healthcare Investors (1996–2014)

The table below shows the annual cash flow conversion efficiency of Tekla Healthcare Investors from 1996 to 2014. View Tekla Healthcare Investors stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2014-09-30 $1.05 Billion $-141.08 Million -0.134x -553.81%
2013-09-30 $690.10 Million $20.37 Million 0.030x -42.89%
2012-09-30 $510.40 Million $26.38 Million 0.052x +5.23%
2011-09-30 $378.90 Million $18.61 Million 0.049x +67.01%
2010-09-30 $365.20 Million $10.74 Million 0.029x +493.92%
2009-09-30 $356.30 Million $-2.66 Million -0.007x +53.86%
2008-09-30 $403.00 Million $-6.52 Million -0.016x -39.75%
2007-09-30 $444.00 Million $-5.14 Million -0.012x -8.47%
2006-09-30 $385.10 Million $-4.11 Million -0.011x +16.32%
2005-09-30 $417.10 Million $-5.32 Million -0.013x +3.28%
2004-09-30 $369.30 Million $-4.87 Million -0.013x -13.92%
2003-09-30 $286.80 Million $-3.32 Million -0.012x +25.69%
2002-09-30 $242.00 Million $-3.77 Million -0.016x -109.45%
2001-09-30 $329.40 Million $-2.45 Million -0.007x -39.45%
2000-09-30 $485.60 Million $-2.59 Million -0.005x +59.87%
1998-09-30 $158.00 Million $-2.10 Million -0.013x -65.30%
1997-09-30 $207.70 Million $-1.67 Million -0.008x +41.25%
1996-09-30 $147.60 Million $-2.02 Million -0.014x --

About Tekla Healthcare Investors

NYSE:HQH USA Asset Management
Market Cap
$1.18 Billion
Market Cap Rank
#8656 Global
#2474 in USA
Share Price
$21.24
Change (1 day)
-0.23%
52-Week Range
$17.25 - $24.66
All Time High
$24.66
About

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs funda… Read more